Your browser doesn't support javascript.
loading
Recommendations of a gropu of experts for the pathological assessment of tumor regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant theray
Gómez Dorronsoro, ML; Vera, R; Ortega, L; Plaza, C; Miquel, R; García, M; Díaz, E; Ortiz, MR; Pérez, J; Hörndler, C; Villar, C; Antúnez, J; Pereira, S; López-Rios, F; González-Cámpora, R.
Affiliation
  • Gómez Dorronsoro, ML; Hospital de Navarra. Pamplona. Spain
  • Vera, R; Hospital de Navarra. Pamplona. Spain
  • Ortega, L; Hospital Clínico San Carlos. Madrid. Spain
  • Plaza, C; Hospital HM Universitario Sanchinarro. Centro Integral Oncológico Clara Campal. Madrid. Spain
  • Miquel, R; Hospital Clínic de Barcelona. Barcelon. Spain
  • García, M; Hospital del Mar. Barcelona. Spain
  • Díaz, E; Hospital de Girona Dr. Josep Trueta. Madrid. Spain
  • Ortiz, MR; Hospital de Girona Dr. Josep Trueta. Madrid. Spain
  • Pérez, J; Hospital Universitario La Fe. Valencia. Spain
  • Hörndler, C; Hospital Miguel Servet. Zaragoza. Spain
  • Villar, C; Hospital Universitario Reina Sofía. Córdoba. Spain
  • Antúnez, J; Complejo Hospitalario Universitario de Santiago de Compostela. Santiago de Compostela. Spain
  • Pereira, S; Hospital Universitario Virgen Macarena. Sevilla. Spain
  • López-Rios, F; Hospital HM Universitario Sanchinarro. Centro Integral Oncológico Clara Campal. Madrid. Spain
  • González-Cámpora, R; Hospital Universitario Virgen Macarena. Sevilla. Spain
Clin. transl. oncol. (Print) ; 16(3): 234-242, mar. 2014.
Article in En | IBECS | ID: ibc-127730
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Colorectal cancer (CRC) incidence has increased during the past decades in Spain, being the first malignant tumour in incidence. Observed mortality for CRC is mainly due to liver and lung metastases. The only curative treatment is surgery; new surgical techniques and neoadjuvant treatments have increased the number of surgery candidate patients. Patients should be managed with a multidisciplinary approach that includes imaging techniques, chemotherapy, surgery and pathological assessment. As an answer to this approach, a group of pathology experts interested on CRC liver metastases aimed to review the diagnosis and prognosis of liver mestastases and developed practical recommendations for its assessment. The expert group revised the current literature and prepared questions to be discussed based on available evidence and on their clinical practise. As a result, recommendations for the assessment of tumour regression of liver metastases are proposed, which could be implemented in oncology centres allowing assessment standardisation for these patients. Prospective multi-center studies to evaluate these recommendations validity will further contribute to improve the standard care of CRC liver metastases patients (AU)
RESUMEN
No disponible
Subject(s)
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Colorectal Neoplasms / Neoadjuvant Therapy / Liver Neoplasms Type of study: Clinical_trials / Guideline Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Clin. transl. oncol. (Print) Year: 2014 Document type: Article
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Colorectal Neoplasms / Neoadjuvant Therapy / Liver Neoplasms Type of study: Clinical_trials / Guideline Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Clin. transl. oncol. (Print) Year: 2014 Document type: Article